Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

The stability of antimycobacterial drugs in media used for drug susceptibility testing.

Schoutrop ELM, Brouwer MAE, Jenniskens JCA, Ferro BE, Mouton JW, Aarnoutse RE, van Ingen J.

Diagn Microbiol Infect Dis. 2018 Dec;92(4):305-308. doi: 10.1016/j.diagmicrobio.2018.06.015. Epub 2018 Jun 27.

PMID:
30025972
2.

Systematic Review and Meta-analyses of the Effect of Chemotherapy on Pulmonary Mycobacterium abscessus Outcomes and Disease Recurrence.

Pasipanodya JG, Ogbonna D, Ferro BE, Magombedze G, Srivastava S, Deshpande D, Gumbo T.

Antimicrob Agents Chemother. 2017 Oct 24;61(11). pii: e01206-17. doi: 10.1128/AAC.01206-17. Print 2017 Nov.

3.

Failure of the Amikacin, Cefoxitin, and Clarithromycin Combination Regimen for Treating Pulmonary Mycobacterium abscessus Infection.

Ferro BE, Srivastava S, Deshpande D, Pasipanodya JG, van Soolingen D, Mouton JW, van Ingen J, Gumbo T.

Antimicrob Agents Chemother. 2016 Sep 23;60(10):6374-6. doi: 10.1128/AAC.00990-16. Print 2016 Oct.

4.

Moxifloxacin's Limited Efficacy in the Hollow-Fiber Model of Mycobacterium abscessus Disease.

Ferro BE, Srivastava S, Deshpande D, Pasipanodya JG, van Soolingen D, Mouton JW, van Ingen J, Gumbo T.

Antimicrob Agents Chemother. 2016 May 23;60(6):3779-85. doi: 10.1128/AAC.02821-15. Print 2016 Jun.

5.

Tigecycline Is Highly Efficacious against Mycobacterium abscessus Pulmonary Disease.

Ferro BE, Srivastava S, Deshpande D, Pasipanodya JG, van Soolingen D, Mouton JW, van Ingen J, Gumbo T.

Antimicrob Agents Chemother. 2016 Apr 22;60(5):2895-900. doi: 10.1128/AAC.03112-15. Print 2016 May.

6.

Amikacin Pharmacokinetics/Pharmacodynamics in a Novel Hollow-Fiber Mycobacterium abscessus Disease Model.

Ferro BE, Srivastava S, Deshpande D, Sherman CM, Pasipanodya JG, van Soolingen D, Mouton JW, van Ingen J, Gumbo T.

Antimicrob Agents Chemother. 2015 Dec 7;60(3):1242-8. doi: 10.1128/AAC.02282-15.

7.

Clofazimine Prevents the Regrowth of Mycobacterium abscessus and Mycobacterium avium Type Strains Exposed to Amikacin and Clarithromycin.

Ferro BE, Meletiadis J, Wattenberg M, de Jong A, van Soolingen D, Mouton JW, van Ingen J.

Antimicrob Agents Chemother. 2015 Dec 7;60(2):1097-105. doi: 10.1128/AAC.02615-15. Print 2016 Feb.

8.

Genotypic Analysis of Genes Associated with Independent Resistance and Cross-Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis Clinical Isolates.

Rueda J, Realpe T, Mejia GI, Zapata E, Rozo JC, Ferro BE, Robledo J.

Antimicrob Agents Chemother. 2015 Dec;59(12):7805-10. doi: 10.1128/AAC.01028-15. Epub 2015 Sep 14.

9.

Time-kill kinetics of slowly growing mycobacteria common in pulmonary disease.

Ferro BE, van Ingen J, Wattenberg M, van Soolingen D, Mouton JW.

J Antimicrob Chemother. 2015 Oct;70(10):2838-43. doi: 10.1093/jac/dkv180. Epub 2015 Jul 4.

PMID:
26142475
10.

Time-kill kinetics of antibiotics active against rapidly growing mycobacteria.

Ferro BE, van Ingen J, Wattenberg M, van Soolingen D, Mouton JW.

J Antimicrob Chemother. 2015 Mar;70(3):811-7. doi: 10.1093/jac/dku431. Epub 2014 Oct 25.

PMID:
25344808
11.

Assessment of children exposed to adult pulmonary tuberculosis in Cali, Colombia.

Villegas SL, Ferro BE, Rojas CM, Perez-Velez CM.

Paediatr Int Child Health. 2014 Aug;34(3):170-7. doi: 10.1179/2046905514Y.0000000128. Epub 2014 Jun 17.

PMID:
24939365
12.

Population structure among mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Colombia.

Realpe T, Correa N, Rozo JC, Ferro BE, Gomez V, Zapata E, Ribon W, Puerto G, Castro C, Nieto LM, Diaz ML, Rivera O, Couvin D, Rastogi N, Arbelaez MP, Robledo J.

PLoS One. 2014 Apr 18;9(4):e93848. doi: 10.1371/journal.pone.0093848. eCollection 2014. Erratum in: PLoS One. 2014;9(9):e109456. Ferro, Beatriz Elena [corrected to Ferro, Beatriz Eugenia].

13.

Drug treatment of pulmonary nontuberculous mycobacterial disease in HIV-negative patients: the evidence.

van Ingen J, Ferro BE, Hoefsloot W, Boeree MJ, van Soolingen D.

Expert Rev Anti Infect Ther. 2013 Oct;11(10):1065-77. doi: 10.1586/14787210.2013.830413. Review.

PMID:
24124798
14.

Predictive value of molecular drug resistance testing of Mycobacterium tuberculosis isolates in Valle del Cauca, Colombia.

Ferro BE, García PK, Nieto LM, van Soolingen D.

J Clin Microbiol. 2013 Jul;51(7):2220-4. doi: 10.1128/JCM.00429-13. Epub 2013 May 8.

15.

High initial multidrug-resistant tuberculosis rate in Buenaventura, Colombia: a public-private initiative.

Villegas SL, Ferro BE, Perez-Velez CM, Moreira CA, Forero L, Martínez E, Rastogi N, Caminero JA.

Eur Respir J. 2012 Dec;40(6):1569-72. doi: 10.1183/09031936.00018212. No abstract available.

16.

Characterization of extensively drug-resistant tuberculosis cases from Valle del Cauca, Colombia.

Nieto LM, Ferro BE, Villegas SL, Mehaffy C, Forero L, Moreira C, Rastogi N, van Soolingen D.

J Clin Microbiol. 2012 Dec;50(12):4185-7. doi: 10.1128/JCM.01946-12. Epub 2012 Sep 19. No abstract available.

17.

Multidrug-resistant Mycobacterium tuberculosis, Southwestern Colombia.

Ferro BE, Nieto LM, Rozo JC, Forero L, van Soolingen D.

Emerg Infect Dis. 2011 Jul;17(7):1259-62. doi: 10.3201/eid1707.101797.

18.

[Clinical, epidemiological and microbiological characteristics of a cohort of pulmonary tuberculosis patients in Cali, Colombia].

Rojas CM, Villegas SL, Piñeros HM, Chamorro EM, Durán CE, Hernández EL, Pacheco R, Ferro BE.

Biomedica. 2010 Oct-Dec;30(4):482-91. Spanish.

19.

[Seroprevalence of Leptospira infection in habitants of peripheral neighborhoods in Cali, Colombia].

Ferro BE, Rodríguez AL, Pérez M, Travi BL.

Biomedica. 2006 Jun;26(2):250-7. Spanish.

PMID:
16925097
20.

[Exposure to Leptospira in stray dogs in the city of Cali].

Rodríguez AL, Ferro BE, Varona MX, Santafé M.

Biomedica. 2004 Sep;24(3):291-5. Spanish.

PMID:
15551881
21.

[Initial drug resistance as a threat for tuberculosis control: the case of Buenaventura, Colombia].

Moreira CA, Hernández HL, Arias NL, Castaño MC, Ferro BE, Jaramillos E.

Biomedica. 2004 Jun;24 Supp 1:73-9. Spanish.

PMID:
15495574
22.

Polymorphisms in cg2 and pfcrt genes and resistance to chloroquine and other antimalarials in vitro in Plasmodium falciparum isolates from Colombia.

González IJ, Varela RE, Murillo C, Ferro BE, Salas J, Giraldo LE, Zalis MG, Saravia NG.

Trans R Soc Trop Med Hyg. 2003 May-Jun;97(3):318-24.

PMID:
15228252
23.

Photographic and luminometric detection of luciferase reporter phages for drug susceptibility testing of clinical Mycobacterium tuberculosis isolates.

Hazbón MH, Guarín N, Ferro BE, Rodríguez AL, Labrada LA, Tovar R, Riska PF, Jacobs WR Jr.

J Clin Microbiol. 2003 Oct;41(10):4865-9.

24.
25.

Performance of OptiMAL(R) in the diagnosis of Plasmodium vivax and Plasmodium falciparum infections in a malaria referral center in Colombia.

Ferro BE, Gonzalez IJ, Carvajal Fd, Palma GI, Saravia NG.

Mem Inst Oswaldo Cruz. 2002 Jul;97(5):731-5.

Supplemental Content

Loading ...
Support Center